Skip to main content
Premium Trial:

Request an Annual Quote

As I've Already Said …

Given the nature of scientific discovery where findings can build on previous work, it's not illogical to think that sooner or later, researchers will "self-cite," says Bar-Ilan University graduate student Hadas Shema at the Scientific American Information Culture blog. But at the same time, self-citation is also considered "vanity, egotism, or an attempt in self-advertising," she adds. The debate over whether self-citation should count as part of a paper's overall citation count or as part of a journal's impact factor is ongoing, though today's JIFs do include self-citations.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.